Endogenous interferon alpha production pathway (IFN-alpha production pathway)

The endogenous interferon alpha production pathway is a specialized innate immune signaling cascade primarily localized within plasmacytoid dendritic cells (pDCs), which are the professional producers of Type I interferons (IFNs) (Swiecki & Colonna, 2015). This pathway is triggered when pattern recognition receptors (PRRs), specifically Toll-like receptors 7 and 9 (TLR7/9) located in endosomal compartments, detect viral or endogenous nucleic acids (Gilliet et al., 2008). Activation of these receptors leads to the recruitment of the adapter protein MyD88 and the subsequent phosphorylation and nuclear translocation of Interferon Regulatory Factor 7 (IRF7), which drives the high-level transcription of IFN-alpha genes (Swiecki & Colonna, 2015). While essential for host defense against viral infections, chronic overproduction of IFN-alpha is a central driver in the pathogenesis of autoimmune diseases like systemic lupus erythematosus (SLE), where it promotes the loss of self-tolerance and tissue damage (Banchereau et al., 2016). Pharmacological modulation of this pathway involves either inhibiting production using BDCA2 agonists like litifilimab or TLR7/8/9 antagonists to treat autoimmunity, or stimulating it using TLR agonists like imiquimod for antiviral or oncological applications (Furie et al., 2022; Musumeci et al., 2019). Monitoring the pathway's activity is often achieved through the measurement of an "interferon signature," a panel of interferon-stimulated genes (ISGs) that serves as a robust biomarker for disease activity and treatment response (Banchereau et al., 2016). Therapeutic challenges include the risk of increased viral susceptibility when the pathway is suppressed and the potential for systemic inflammatory responses when it is over-stimulated (Furie et al., 2022).

Other names

Type I interferon production pathwaypDC interferon alpha pathwayTLR-mediated IFN-alpha inductionInterferon-alpha signaling cascade

Modulation of pattern recognition receptors (PRRs) such as TLR7, TLR8, and TLR9, or surface receptors like BDCA2 on plasmacytoid dendritic cells (pDCs) to either stimulate or suppress the transcription and secretion of interferon-alpha.